STI Capacity Raising, FHI 360, New Delhi 110016, India.
Sex Transm Infect. 2013 Feb;89(1):5-10. doi: 10.1136/sextrans-2012-050472. Epub 2012 Nov 29.
Female sex workers (FSWs) in India are provided a standardised package of clinical interventions for management of sexually transmitted infections (STIs). A study was conducted among FSWs at known high STI prevalence sites to determine the effectiveness of the service package.
A cohort of FSW clinic attendees in two cities, Hyderabad and Mumbai, were enrolled and followed up from October 2008 to November 2009. At each visit, behavioural and clinical data were obtained and vaginal swabs collected for laboratory testing of cervical infections (gonorrhoea and chlamydia).
417 participants were enrolled, of whom 360 attended at least a follow-up visit. Prevalence of cervical infections did not change between the baseline and final visits (27.7% and 21.3% respectively, p=0.08) in spite of presumptive treatment at baseline and syndromic management at all visits. The proportion of asymptomatic cervical infections increased from 36% at baseline to 77% at the final visit. Incidence rate of cervical infections was high (85.6/100 person years) and associated with a prevalent cervical infection at baseline (HR=2.7, p<0.001) and inconsistent condom use with non-commercial partners (HR=2.5, p=0.014).
High rates of STIs persisted despite the interventions due to poor condom use, minimal partner treatment, and high prevalence and incidence of STIs with a large proportion of asymptomatic infections. High-prevalence FSW sites in India need to design more effective partner treatment strategies and consider increasing the frequency of presumptive treatment as a temporary measure for quickly reducing STI prevalence, with renewed emphasis on consistent condom use with all partners.
印度为女性性工作者(FSW)提供了一套标准化的临床干预方案,用于管理性传播感染(STI)。在已知 STI 高发地区对 FSW 进行了一项研究,以确定该服务套餐的有效性。
在海得拉巴和孟买两个城市的 FSW 诊所招募了一组参与者,并对其进行了随访,随访时间从 2008 年 10 月到 2009 年 11 月。每次就诊时,都会收集性行为和临床数据,并采集阴道拭子进行实验室检测,以检测宫颈感染(淋病和衣原体)。
共招募了 417 名参与者,其中 360 名至少参加了一次随访。尽管在基线时进行了疑似治疗,所有就诊时都进行了症状管理,但宫颈感染的患病率在基线和最后一次就诊时并没有变化(分别为 27.7%和 21.3%,p=0.08)。无症状宫颈感染的比例从基线时的 36%增加到最后一次就诊时的 77%。宫颈感染的发病率很高(85.6/100 人年),且与基线时存在宫颈感染(HR=2.7,p<0.001)和与非商业性伴侣不持续使用安全套(HR=2.5,p=0.014)相关。
尽管采取了干预措施,但由于安全套使用率低、对性伴侣的治疗很少、STI 的患病率和发病率高,且无症状感染比例大,因此 STI 的高发病率仍持续存在。印度高流行的 FSW 地区需要设计更有效的性伴侣治疗策略,并考虑增加疑似治疗的频率,作为迅速降低 STI 患病率的临时措施,同时重新强调与所有性伴侣持续使用安全套。